Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
89,159.00
87,311.00
75,725.00
68,383.00
59,532.00
52,757.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
89,159.00
87,311.00
75,725.00
68,383.00
59,532.00
52,757.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
501.00
452.00
457.00
337.00
315.00
238.00
General and Administration Expenses
43,316.00
41,805.00
36,737.00
32,646.00
30,992.00
28,073.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
76,784.00
75,113.00
66,008.00
59,368.00
53,166.00
49,281.00
Operating Profit (PBDIT) excl Other Income
12,374.00
12,197.00
9,716.00
9,014.00
6,366.00
3,475.00
Other Income
-672.00
1,081.00
-250.00
-1,082.00
-100.00
343.00
Operating Profit (PBDIT)
19,049.00
20,834.00
17,021.00
14,080.00
11,665.00
8,254.00
Interest
501.00
452.00
457.00
337.00
315.00
238.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
7,347.00
7,554.00
7,555.00
6,148.00
5,400.00
4,436.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
11,200.00
12,618.00
9,508.00
7,272.00
5,721.00
3,956.00
Provision for Tax
2,782.00
2,650.00
1,813.00
1,065.00
1,746.00
801.00
Profit After Tax
8,454.00
9,936.00
7,731.00
6,195.00
3,961.00
3,143.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
191.80
225.42
175.39
140.26
87.76
68.22
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 2.12% vs 15.30% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 1.45% vs 25.53% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 10.95% vs -1.20% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -14.91% vs 28.52% in Mar 2025
Compare Profit and Loss Results of Zeria Pharmaceutical Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
89,159.00
1,26,257.00
-37,098.00
-29.38%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
89,159.00
1,26,257.00
-37,098.00
-29.38%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
501.00
254.00
247.00
97.24%
General and Administration Expenses
43,316.00
35,995.00
7,321.00
20.34%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
76,784.00
1,22,699.00
-45,915.00
-37.42%
Operating Profit (PBDIT) excl Other Income
12,374.00
3,558.00
8,816.00
247.78%
Other Income
-672.00
1,096.00
-1,768.00
-161.31%
Operating Profit (PBDIT)
19,049.00
9,317.00
9,732.00
104.45%
Interest
501.00
254.00
247.00
97.24%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
7,347.00
4,663.00
2,684.00
57.56%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
11,200.00
4,451.00
6,749.00
151.63%
Provision for Tax
2,782.00
1,002.00
1,780.00
177.64%
Profit After Tax
8,454.00
3,448.00
5,006.00
145.19%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
191.8024
60.0196
131.78
219.57%
Profit And Loss - Net Sales
Net Sales 89,159.26 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 2.12% vs 15.30% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12,374.45 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 1.45% vs 25.53% in Mar 2025
Profit And Loss - Interest
Interest 501.80 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 10.95% vs -1.20% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 8,454.54 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -14.91% vs 28.52% in Mar 2025






